Stay updated on Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.8.0 to v3.8.1.
    Difference
    0.0%
    Check dated 2026-11-18T01:37:32.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the rebastinib–carboplatin study is now available, with study design, eligibility, locations, outcomes, and documents. It indicates that the study is terminated and no longer recruiting participants.
    Difference
    74%
    Check dated 2026-11-10T22:46:44.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2. The study record still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T22:51:45.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    A sitewide NIH transition notice appears above the study page, which still shows a 403 error instead of the study record. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:05:21.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The revision identifier in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T21:50:47.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, replacing the expected study record content and leaving the standard header and footer visible.
    Difference
    0.5%
    Check dated 2026-09-29T22:10:21.000Z thumbnail image

Stay in the know with updates to Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial page.